Abstract
Purpose
We investigated the breast cancer survival disparity between Indigenous Māori and non-Indigenous European women in New Zealand, and quantified the relative contributions of patient, tumor and healthcare system factors toward this disparity.
Methods
All women diagnosed with breast cancer in Waikato, New Zealand, during 1999–2012 were identified from the Waikato Breast Cancer Register. Cancer-specific survivals were compared using Kaplan–Meier survival curves, while contributions of different factors toward the survival disparity were quantified with serial Cox proportional hazard modeling.
Results
Of the 2,679 women included in this study, 2,260 (84.4 %) were NZ European and 419 (15.6 %) were Māori. Compared with NZ European women, Māori women had a significantly higher age-adjusted cancer-specific mortality (HR 2.02, 95 % CI 1.59–2.58) with significantly lower 5-year (86.8 vs. 76.1 %, p < 0.001) and 10-year (79.9 vs. 66.9 %, p < 0.001 %) crude cancer-specific survivals. Stage at diagnosis made the greatest contribution (approximately 25–40 %), while screening, treatment and patient factors (i.e., comorbidity, obesity and smoking) contributed by approximately 15 % each toward the survival disparity. The final model accounted for almost all of the cancer survival disparity (HR 1.07, 95 % CI 0.80–1.44).
Conclusions
Māori women experience an age-adjusted risk of death from breast cancer, which is more than twice that for NZ European women. Equity-focussed improvements in health care, including increasing mammographic screening coverage and providing equitable quality and timely cancer care, may improve the survival disparity between Māori and NZ European women.
Similar content being viewed by others
References
Ward E, Jemal A, Cokkinides V, Singh GK, Cardinez C, Ghafoor A, Thun M (2004) Cancer disparities by race/ethnicity and socioeconomic status. CA Cancer J Clin 54(2):78–93
Bramley D, Hebert P, Jackson R, Chassin M (2004) Indigenous disparities in disease-specific mortality, a cross-country comparison: New Zealand, Australia, Canada, and the United States. N Z Med J 117(1207):U1215
Condon JR, Armstrong BK, Barnes A, Cunningham J (2003) Cancer in Indigenous Australians: a review. Cancer Causes Control 14(2):109–121
Ajwani S, Blakely T, Robson B, Tobias M, Bonne M (2003) Decades of disparity: ethnic mortality trends in New Zealand 1980–1999. Ministry of Health and University of Otago, New Zealand
Robson B, Purdie G, Cormack D (2010) Unequal impact II: Maori and Non-Maori cancer statistics by deprivation and rural–urban status 2002–2006. Ministry of Health, Wellington
Robson B, Harris R (2007) Hauora: Màori standards of health IV. A study of the years 2000–2005. Te Ròpù Rangahau Hauora a Eru Pòmare, Wellington
Bach PB, Schrag D, Brawley OW, Galaznik A, Yakren S, Begg CB (2002) Survival of blacks and whites after a cancer diagnosis. JAMA 287(16):2106–2113
Mandelblatt JS, Yabroff KR, Kerner JF (1999) Equitable access to cancer services: a review of barriers to quality care. Cancer 86(11):2378–2390. doi:10.1002/(SICI)1097-0142(19991201)86:11<2378:AID-CNCR28>3.0.CO;2-L
Shavers VL, Brown ML (2002) Racial and ethnic disparities in the receipt of cancer treatment. J Natl Cancer Inst 94(5):334–357
Phelan JC, Link BG, Tehranifar P (2010) Social conditions as fundamental causes of health inequalities theory, evidence, and policy implications. J Health Soc Behav 51(1 suppl):S28–S40
James WPT, Nelson M, Ralph A, Leather S (1997) Socioeconomic determinants of health: the contribution of nutrition to inequalities in health. BMJ 314(7093):1545
Tammemagi CM, Nerenz D, Neslund-Dudas C, Feldkamp C, Nathanson D (2005) Comorbidity and survival disparities among black and white patients with breast cancer. JAMA 294(14):1765–1772. doi:10.1001/jama.294.14.1765
Carmichael AR (2006) Obesity and prognosis of breast cancer. Obes Rev 7(4):333–340. doi:10.1111/j.1467-789X.2006.00261.x
O’Brien KM, Cole SR, Tse CK, Perou CM, Carey LA, Foulkes WD, Dressler LG, Geradts J, Millikan RC (2010) Intrinsic breast tumor subtypes, race, and long-term survival in the Carolina Breast Cancer Study. Clin Cancer Res 16(24):6100–6110. doi:10.1158/1078-0432.CCR-10-1533
van Ravesteyn NT, Schechter CB, Near AM, Heijnsdijk EA, Stoto MA, Draisma G, de Koning HJ, Mandelblatt JS (2011) Race-specific impact of natural history, mammography screening, and adjuvant treatment on breast cancer mortality rates in the United States. Cancer Epidemiol Biomark Prev 20(1):112–122. doi:10.1158/1055-9965.EPI-10-0944
Bickell NA, Wang JJ, Oluwole S, Schrag D, Godfrey H, Hiotis K, Mendez J, Guth AA (2006) Missed opportunities: racial disparities in adjuvant breast cancer treatment. J Clin Oncol 24(9):1357–1362. doi:10.1200/JCO.2005.04.5799
Elmore JG, Nakano CY, Linden HM, Reisch LM, Ayanian JZ, Larson EB (2005) Racial inequities in the timing of breast cancer detection, diagnosis, and initiation of treatment. Med Care 43(2):141–148. doi:10.1097/00005650-200502000-00007
Cormack D, Purdie G, Ratima M (2005) Access for cancer services for Maori. A report prepared for the Ministry of Health
Hill S, Sarfati D, Blakely T, Robson B, Purdie G, Chen J, Dennett E, Cormack D, Cunningham R, Dew K, McCreanor T, Kawachi I (2010) Survival disparities in Indigenous and non-Indigenous New Zealanders with colon cancer: the role of patient comorbidity, treatment and health service factors. J Epidemiol Community Health 64(2):117–123. doi:10.1136/jech.2008.083816
Stevens W, Stevens G, Kolbe J, Cox B (2008) Ethnic differences in the management of lung cancer in New Zealand. J Thorac Oncol 3(3):237–244. doi:10.1097/JTO.0b013e3181653d0801243894-200803000-00007
Baxter J (2002) Barriers to health care for Mäori with known diabetes: a literature review and summary of issues. Te Röpü Rangahau Hauora a Ngäi Tahu, Dunedin
Page A, Morrell S, Taylor R (2014) BreastScreen Aotearoa: independent monitoring report. Screening and assessment report of women attending BSA, National Screening Unit, Ministry of Health, Wellington
Seneviratne S, Campbell I, Scott N, Coles C, Lawrenson R (2014) Treatment delay for Māori women with breast cancer in New Zealand. Ethn Health. doi:10.1080/13557858.2014.895976
Seneviratne S, Campbell I, Scott N, Shirley R, Peni T, Lawrenson R (2014) Accuracy and completeness of the New Zealand Cancer Registry for staging of invasive breast cancer. Cancer Epidemiol 38(5):638–644. doi:10.1016/j.canep.2014.06.008
Ministry of Health (2004) Ethnicity data protocols for the health and disability sector. http://www.health.govt.nz/publication/ethnicity-data-protocols-health-and-disability-sector. Accessed 15 May 2014
NZDep2006: Index of Deprivation (2007). Department of Public Health, University of Otago, Wellington. Ministry of Health
New Zealand: An Urban/Rural Profile Update (2006). Statistics New Zealand, Wellington
American Joint Committee on Cancer (2010) AJCC cancer staging manual, 7th edn. Springer, New York
Charlson ME, Pompei P, Ales KL, MacKenzie CR (1987) A new method of classifying prognostic comorbidity in longitudinal studies: development and validation. J Chronic Dis 40(5):373–383
McLaughlin JM, Anderson RT, Ferketich AK, Seiber EE, Balkrishnan R, Paskett ED (2012) Effect on survival of longer intervals between confirmed diagnosis and treatment initiation among low-income women with breast cancer. J Clin Oncol 30(36):4493–4500. doi:10.1200/JCO.2012.39.7695
Biagi JJ, Raphael M, King WD, Kong W, Booth CM, Mackillop WJ (2011) The effect of delay in time to adjuvant chemotherapy (TTAC) on survival in breast cancer (BC): a systematic review and meta-analysis. J Clin Oncol 29(15 suppl):1128 (ASCO Annual Meeting Abstracts)
Yu KD, Huang S, Zhang JX, Liu GY, Shao ZM (2013) Association between delayed initiation of adjuvant CMF or anthracycline-based chemotherapy and survival in breast cancer: a systematic review and meta-analysis. BMC Cancer 13:240. doi:10.1186/1471-2407-13-240
Hershman DL, Wang X, McBride R, Jacobson JS, Grann VR, Neugut AI (2006) Delay in initiating adjuvant radiotherapy following breast conservation surgery and its impact on survival. Int J Radiat Oncol Biol Phys 65(5):1353–1360. doi:10.1016/j.ijrobp.2006.03.048
Agresti A (2002) Categorical data analysis. Wiley series in probability and statistics, 2nd edn. Wiley-Interscience, New York
Corp IBM (2013) IBM SPSS Statistics for Windows, Version 22.0. Armonk, NY
Pruitt SL, Shim MJ, Mullen PD, Vernon SW, Amick BC (2009) Association of area socioeconomic status and breast, cervical, and colorectal cancer screening: a systematic review. Cancer Epidemiol Biomark Prev 18(10):2579–2599
Marmot M, Friel S, Bell R, Houweling TA, Taylor S (2008) Closing the gap in a generation: health equity through action on the social determinants of health. Lancet 372(9650):1661–1669
Rosenberg J, Chia YL, Plevritis S (2005) The effect of age, race, tumor size, tumor grade, and disease stage on invasive ductal breast cancer survival in the U.S. SEER database. Breast Cancer Res Treat 89(1):47–54. doi:10.1007/s10549-004-1470-1
Li CI, Malone KE, Daling JR (2002) Differences in breast cancer hormone receptor status and histology by race and ethnicity among women 50 years of age and older. Cancer Epidemiol Biomark Prev 11(7):601–607
Lund MJ, Trivers KF, Porter PL, Coates RJ, Leyland-Jones B, Brawley OW, Flagg EW, O’Regan RM, Gabram SG, Eley JW (2009) Race and triple negative threats to breast cancer survival: a population-based study in Atlanta, GA. Breast Cancer Res Treat 113(2):357–370
Curtis E, Quale C, Haggstrom D, Smith-Bindman R (2008) Racial and ethnic differences in breast cancer survival: how much is explained by screening, tumor severity, biology, treatment, comorbidities, and demographics? Cancer 112(1):171–180. doi:10.1002/cncr.23131
Li CI, Malone KE, Daling JR (2003) Differences in breast cancer stage, treatment, and survival by race and ethnicity. Arch Intern Med 163(1):49–56. doi:10.1001/archinte.163.1.49
Amend K, Hicks D, Ambrosone CB (2006) Breast cancer in African–American women: differences in tumor biology from European–American women. Cancer Res 66(17):8327–8330
Dunn BK, Agurs-Collins T, Browne D, Lubet R, Johnson KA (2010) Health disparities in breast cancer: biology meets socioeconomic status. Breast Cancer Res Treat 121(2):281–292
Seneviratne S, Campbell I, Scott N, Kuper-Hommel M, Round G, Lawrenson R (2014) Ethnic differences in timely adjuvant chemotherapy and radiation therapy for breast cancer in New Zealand: a cohort study. BMC Cancer 14(1):839
Cumming J, Stillman S, Poland M (2008) Who pays what for primary health care?: patterns and determinants of the fees paid by patients in a mixed public-private financing model. Motu Economic and Public Policy Research, Wellington
McKenzie F, Ellison-Loschmann L, Jeffreys M (2010) Investigating reasons for socioeconomic inequalities in breast cancer survival in New Zealand. Cancer Epidemiol 34(6):702–708. doi:10.1016/j.canep.2010.07.007
Ministry of Health (2000) The New Zealand health strategy. Ministry of Health, Wellington
Harris R, Tobias M, Jeffreys M, Waldegrave K, Karlsen S, Nazroo J (2006) Effects of self-reported racial discrimination and deprivation on Maori health and inequalities in New Zealand: cross-sectional study. Lancet 367(9527):2005–2009. doi:10.1016/S0140-6736(06)68890-9
New Zealand Cancer Control Trust (2003) New Zealand Cancer Control Strategy. Wellington
New Zealand Health Information Service (2012) Cancer patient survival : change over time update: covering the period 1994–2009. Wellington
Campbell NC, Elliott AM, Sharp L, Ritchie LD, Cassidy J, Little J (2000) Rural factors and survival from cancer: analysis of Scottish cancer registrations. Br J Cancer 82(11):1863–1866. doi:10.1054/bjoc.1999.1079
Ministry of Health (2013) Standards of Service Provision for Breast Cancer Patients in New Zealand (Provisional). Wellington
Lannin DR, Mathews HF, Mitchell J, Swanson MS, Swanson FH, Edwards MS (1998) Influence of socioeconomic and cultural factors on racial differences in late-stage presentation of breast cancer. JAMA 279(22):1801–1807
Acknowledgments
We acknowledge funding support received from the Waikato Breast Cancer Trust, Waikato Bay of Plenty Division of the Cancer Society of New Zealand, New Zealand Breast Cancer Foundation, Lion Foundation, Grassroots Trust and WEL energy trust for the WBCR.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Conflicts of interest
All authors declare that there are no conflicts of interest.
Ethics approval
Ethical approval for this study was obtained from the New Zealand Northern ‘A’ Ethics Committee (Ref. No. 12/NTA/42).
Rights and permissions
About this article
Cite this article
Seneviratne, S., Campbell, I., Scott, N. et al. Ethnic differences in breast cancer survival in New Zealand: contributions of differences in screening, treatment, tumor biology, demographics and comorbidities. Cancer Causes Control 26, 1813–1824 (2015). https://doi.org/10.1007/s10552-015-0674-5
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10552-015-0674-5